The segregation analysis, when available, highlighted two major results: CHEK2 variants c.793-1G>A and p.(Ile157Thr) were found in a ccRCC case and in a subject diagnosed with in situ melanoma, respectively. The gene discussed is CHEK2; the disease is in situ carcinoma.